Given their central role in fibrosis, fibroblast foci represent a potential therapeutic target. Several strategies are being explored to inhibit fibroblast activation and reduce extracellular matrix production. These include the use of anti-fibrotic drugs, small molecule inhibitors, and gene therapies. The goal is to halt or reverse the fibrotic process and preserve tissue function.
